INOVELON susp 40 mg/ml fl 460 ml

7680620660018 CH-62066 N03AF03 01.07.1.

Active substances:

INOVELON susp 40 mg/ml fl 460 ml
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6206601
CPT
-
Packaging group
460
Unit
ml
Composition
rufinamidum 40 mg, sorbitolum liquidum non cristallisabile corresp. sorbitolum 175 mg, propylenglycolum 25 mg, cellulosum microcristallinum, carmellosum natricum, acidum citricum, hydroxyethylcellulosum, dimeticonum, polysorbatum 65, methylcellulosum, silica colloidalis hydrica, macrogoli stearas, E 210 max. 0.005 mg, E 200, acidum sulfuricum, poloxamerum 188, aromatica (Orange) cum alcohol benzylicus, E 202, E 218 1.2 mg, propylis parahydroxybenzoas 0.3 mg, aqua purificata, ad suspensionem pro 1 ml corresp. natrium max. 0.22 mg.

Articles (1)

Inovelon, Suspension zum Einnehmen
suspension
460
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
rufinamidum
40.0 MG Substance Wirkstoff (Principe actif)
sorbitolum liquidum non cristallisabile
- Substance HNIDK
sorbitolum
175.0 MG Substance HBESI
propylenglycolum
25.0 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
carmellosum natricum
- Substance HNIDK
acidum citricum
- Substance HNIDK
hydroxyethylcellulosum
- Substance HNIDK
dimeticonum
- Substance HNIDK
polysorbatum 65
- Substance HNIDK
methylcellulosum
- Substance HNIDK
silica colloidalis hydrica
- Substance HNIDK
macrogoli stearas
- Substance HNIDK
E 210
- Substance HBESI
E 200
- Substance Konservierungsstoff (Conservateur)
acidum sulfuricum
- Substance HNIDK
poloxamerum 188
- Substance HNIDK
aromatica
- Substance AROMA
alcohol benzylicus
- Substance HBESI
E 202
- Substance Konservierungsstoff (Conservateur)
E 218
1.2 MG Substance HBESI
propylis parahydroxybenzoas
0.3 MG Substance HBESI
aqua purificata
- Substance HNIDK
natrium
- Substance HBESI

Reimbursement information

Public price
CHF 90.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2012

Authorization holder

Eisai Pharma AG

8050 Zürich

Authorization information

Swissmedic authorization number
62066
Drug name
Inovelon, Suspension zum Einnehmen
Galenic form
SUOR
ATC Code
N03AF03
Authorization status
Z
Dispensation category
B
First authorization
13/06/2012
Authorization expiration date
31/12/9999
IT number
01.07.1.
Domain
Human medicine
Field of application
Zusatztherapie zur Behandlung von Anfällen bei Lennox-Gastaut-Syndrom bei Patienten ab dem 1. Lebensjahr

Packaging details

Description (FR)
INOVELON susp 40 mg/ml fl 460 ml
Description (DE)
INOVELON Susp 40 mg/ml Fl 460 ml
Market launch
13/06/2012
Narcotic (BTM)
No
Buy us a coffee Explore the data